COVID-19 Vaccine Roll Outs in ASEAN & Asia – Live Updates by Country
(This article will be updated continuously. It was originally published on January 28, 2020. It was last updated on September 20, 2021)
Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations.
Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running live update service to keep businesses involved in ASEAN and Asia updated with the latest relevant regional news.
For specific updates concerning China and related business advisory, please click here.
Please refresh the page to get the latest updates.
ASEAN coronavirus updates (Live updates by country)
Brunei has joined the global Covax scheme and is expecting to have the COVID-19 vaccine in Q1 2021, having sourced enough supplies to cover 50% of the population. Discussions are on-going with other suppliers.
- Brunei recorded 214 new cases and two deaths on September 20, bringing the tallies to 5,261 cases and 28 deaths.
- Brunei saw 90 new cases on September 19, taking the total to 5,047 cases amid 26 deaths.
- Brunei saw 143 new cases and two deaths on September 18, bringing the totals to 4,957 cases and 26 deaths.
Cambodia is expected to import vaccines from both China and Russia. China’s vaccines are still undergoing clinical trials while Russia has already commenced production. Australia has offered financial support to aid vaccine coverage in several southeast Asia countries including Cambodia.
- Cambodia reported 622 new cases and 14 deaths on September 20, taking the tallies to 104,716 cases and 2,123 deaths.
- Cambodia recorded 612 new cases and 13 deaths on September 19, bringing the totals to 104,094 cases and 2,109 deaths.
- Cambodia saw 648 new cases and seven deaths on September 18, taking the tallies to 103,482 cases and 2,096 deaths.
Indonesia has commenced vaccinations with just over nine million doses being given to front line workers from last month. China’s Sinovac is in discussions with Indonesia to provide supplies, however, the Government faces difficulties with a large population of 270 million. Indonesia’s Health Ministry’s Disease Control and Prevention Director-General Achmad Yurianto said that vaccinations would only be provided to citizens aged 18-59. The vaccine has also been required to pass halal certification prior to use and it is uncertain how the country can source enough vaccines to reach a sizeable part of its population.
- Indonesia reported 1,932 new cases and 166 deaths on September 20, taking the totals to 4,192,695 cases and 140,634 deaths.
- Indonesia saw 2,234 new cases and 145 deaths on September 19, bringing the tallies to 4,190,763 cases and 140,468 deaths.
- Indonesia recorded 3,385 new cases and 185 deaths on September 18, taking the totals to 4,188,529 cases and 140,323 deaths.
Laos has been trialing the Russian Sputnik V vaccine and is also in discussions with China about acquiring supplies.
- Laos reported 371 new cases on September 19, taking the total to 19,185 cases amid 16 deaths.
- Laos recorded 467 new cases on September 17, taking the total to 18,814 cases amid 16 deaths.
- Laos saw 154 new cases on September 16, bringing the total to 18,059 cases amid 16 deaths.
Malaysia is to provide vaccines free of charge to its nationals, but foreigners will need to pay for the treatment, according to the Malaysian Minister of Health, Tan Sri Muhyiddin Yassin, who has signed a deal with Pfizer for 12.8 million doses. These will be administered in two stages of 6.4 million people each, with the program to commence in Q1 2021. The country aims to inoculate between 80-100% of its citizens.
- Malaysia reported 14,954 new cases and 376 deaths on September 19, bringing the totals to 2,097,830 cases and 23,443 deaths.
- Malaysia saw 15,549 new cases and 324 deaths on September 18, taking the tallies to 2,082,876 cases and 23,067 deaths.
- Malaysia recorded 17,577 new cases and 388 deaths on September 17, bringing the totals to 2,067,327 cases and 22,743 deaths.
Myanmar is seeking assistance from the Gavi and Covax programs to acquire vaccines, while Australia is also providing financial relief. At present, the Government aims to treat 20 percent of the ‘most at risk’ in the country with vaccines. The Government is struggling with finances and logistics and is also under US sanctions, while cases are surging. The Government has banned the celebration of Christmas and other seasonal celebrations.
- Myanmar saw 1,702 new cases and 57 deaths on September 19, taking the totals to 446,573 cases and 17,073 deaths.
- Myanmar recorded 1,943 new cases and 72 deaths on September 18, bringing the tallies to 444,871 cases and 17,016 deaths.
- Myanmar reported 2,187 new cases and 75 deaths on September 17, taking the totals to 442,928 cases and 16,944 deaths.
The Philippines aims to commence vaccinations from June 2021 and expects to inoculate about 25 million people (about 25 percent of its population) over the course of the year. The country has been badly affected by the virus and has the second-highest rate in Southeast Asia. The business community has reacted, more than 30 local companies signed an agreement to purchase at least 2.6 million vaccine doses from AstraZeneca in the country’s first such deal to secure coronavirus vaccines, ten days ago. They plan to donate a large part of the doses to the government for its planned vaccination program and use the rest to inoculate their employees.
- The Philippines saw 18,937 new cases and 146 deaths on September 20, taking the tallies to 2,385,616 cases and 36,934 deaths.
- The Philippines recorded 19,271 new cases and 205 deaths on September 19, bringing the totals to 2,366,749 cases and 36,788 deaths.
- The Philippines reported 23,134 new cases and 255 deaths on September 18, bringing the tallies to 2,347,550 cases and 36,583 deaths.
Singapore has been working on producing its own ‘Lunar’ vaccine, in a joint venture between the US company Arcturus together with the Duke-NUS medical school. It is a single dose, mRNA shot, developed from genetically engineering COVID-19 genes into an otherwise harmless virus. This technique is marginally safer than other vaccines which rely on dead Covid-19 material to provoke an immune response. The vaccine is expected to be available from Q1 2021. High-risk personnel will receive the vaccine first in a process to be determined by the government.
- Singapore saw 1,012 new cases on September 19, taking the total to 77,804 cases amid 60 deaths.
- Singapore recorded 1,009 new cases and one death on September 18, taking the tallies to 76,792 cases and 60 deaths.
- Singapore saw 935 new cases on September 17, bringing the totals to 75,783 cases amid 59 deaths.
Thailand is currently expecting vaccines to be delivered in mid-2021. The doses would cover 13 million people in a population of about 69 million. Thailand’s National Vaccine Institute signed a non-refundable advance market commitment contract worth 2.38 billion baht (US$79 million) with AstraZeneca to reserve the supplies. Discussions are also on-going with Oxford University in the UK to secure a vaccine that could be available in Q1 if trials are completed in time.
- Thailand saw 12,709 new cases and 106 deaths on September 20, bringing the totals to 1,489,186 cases and 15,469 deaths.
- Thailand reported 13,576 new cases and 117 deaths on September 19, taking the tallies to 1,476,477 cases and 15,363 deaths.
- Thailand recorded 14,109 new cases and 122 deaths on September 18, bringing the totals to 1,462,901 cases and 15,246 deaths.
Vietnam’s National Institute of Hygiene and Epidemiology (NIHE), a division of Vietnam’s Ministry of Health, has signed an agreement with Medigen Vaccine, a Taipei, Taiwan-based vaccine company to secure the supply of 3 million to 10 million COVID-19 vaccine doses in 2021. Medigen is currently conducting Phase II studies of the vaccine, co-developed with the USA’s National Institutes of Health (NIH), in Taiwan and Vietnam with a view to a Q1 2021 rollout.
Vietnam is also working on producing its own vaccine, with the Institute of Vaccines and Medical Biologicals (IVAC) in Nha Trang City, partnering with New York City-based Icahn School of Medicine and the global health non-profit organization PATH. Phase 1 trials are already underway in Vietnam, while Phases 2 & 3 will be conducted at the beginning of 2021. The institute plans to submit documents for approval to the health ministry as early as April next year and claims to be capable of producing 30 million doses a year, expecting that a national vaccine could be distributed to the general population in October 2021.
As of September 20, 2021, Vietnam’s Ministry of Health confirmed a total of 695,744 cases of COVID-19. However, 457,505 of the affected patients have recovered and been discharged from hospitals. Vietnam has also recorded 17,305 deaths due to the pandemic. The latest community transmission cases have been reported from Ho Chi Minh City, Binh Duong, Dong Nai, An Giang, and Long An among others.
- Vietnam recorded 10,040 new cases and 233 deaths on September 19, bringing the tallies to 687,063 cases and 17,090 deaths.
- Vietnam saw 9,373 new cases and 220 deaths on September 18, taking the total to 677,023 cases and 16,857 deaths.
Other Asian countries and Regions
Afghanistan faces two pandemics at the same time, Covid-19 and Polio. UNICEF is currently embarking on an urgent Polio vaccination program while the country is in talks with both China and Russia oversupplying COVID-19 vaccines. Government-imposed lockdowns increased conflict with the Taliban, and an overall lack of awareness of the disease has prevented many Afghani from obtaining treatment of either.
- Afghanistan has 154,585 cases and 7,199 deaths as of September 19.
- As of September 18, Afghanistan has 154,536 cases and 7,199 deaths.
- Afghanistan has 154,532 cases and 7,195 deaths as of September 17.
Bangladesh will receive 68 million doses of the COVID-19 vaccine from Gavi, which is committed to ensuring at least 20 percent of populations are inoculated. Each complete dose will cost about 200 Taka (US$2). The country is also in discussions with India concerning a further 30 million doses from the Serum Institute at about 450 Taka (US$5). Vaccinations are expected to commence in Q1 2021.
- As of September 20, Bangladesh has 1,544,238 cases and 27,251 deaths.
- Bangladesh has 1,542,683 cases and 27,225 deaths as of September 19.
- Bangladesh has 1,541,300 cases and 27,182 deaths as of September 18.
Bahrain has begun COVID-19 vaccinations for front line personnel using a joint Chinese-UAE Sinopharm product. Roll out among the general population is expected in Q1 2021.
- Bahrain has 274,264 cases and 1,388 deaths as of September 19.
- As of September 18, Bahrain has 274,179 cases and 1,388 deaths.
- As of September 17, Bahrain has 274,107 cases and 1,388 deaths.
For specific updates concerning China, please click here.
For a complete overview of China’s vaccine availability please go here.
- China saw 49 new cases on September 20, taking the total to 95,738.
- China reported 66 new cases on September 19, taking the total to 95,689.
- China recorded 46 new cases on September 18, bringing the total to 95,623.
East Timor is receiving assistance from the Gavi Institute.
- East Timor has 19,058 cases and 105 deaths as of September 20.
- As of September 19, East Timor has 19,033 cases and 104 deaths.
- East Timor has 18,994 cases and 103 deaths as of September 18.
Hong Kong will provide COVID-19 vaccines free to all residents, with a vaccine being delivered in stages. The government has said it may take most of 2021 to reach 100 percent coverage for all citizens.
- As of September 20, Hong Kong has 12,166 cases and 213 deaths.
- Hong Kong has 12,161 cases and 213 deaths as of September 19.
- As of September 18, Hong Kong has 12,158 cases and 213 deaths.
For a complete overview of India’s vaccine availability please go here.
- India has 33,477,819 cases and 445,165 deaths as of September 19.
- As of September 18, India has 33,447,010 cases and 444,869 deaths.
- Our new India-specific updates can be found here.
Iran is jointly producing a COVID-19 vaccine with Russia, and the product has entered trials. National inoculation is expected to commence in September 2021.
- Iran has 5,442,232 cases and 117,526 deaths as of September 20.
- As of September 19, Iran has 5,424,835 cases and 117,182 deaths.
- Iran has 5,408,860 cases and 116,791 deaths as of September 18.
Iraq is currently in discussions with US company Pfizer concerning supplies of a COVID-19 vaccine. Supplies are expected in Q2 2021.
- Iraq has 1,975,220 cases and 21,822 deaths as of September 19.
- Iraq has 1,972,705 cases and 21,775 deaths as of September 18.
- As of September 17, Iraq has 1,970,746 cases and 21,739 deaths.
Japan is sourcing 145 million doses of vaccine from the United States and the UK and will be delivering them free of charge to all citizens commencing Q1 2021.
- As of September 20, Japan has 1,676,711 cases and 17,204 deaths.
- Japan has 1,673,144 cases and 17,156 deaths as of September 19.
- As of September 18, Japan has 1,668,136 cases and 17,097 deaths.
Jordan is sourcing vaccines from Pfizer and expects to commence vaccinations from Q1 2021.
- As of September 19, Jordan has 813,601 cases and 10,616 deaths.
- Jordan has 812,681 cases and 10,606 deaths as of September 18.
- Jordan has 812,253 cases and 10,594 deaths as of September 17.
Kazakhstan has been developing its own vaccines with ‘Quazcovid’ being admitted by the WHO as a safe candidate. These are currently undergoing trials with a roll out expected in Q2 2021.
- As of September 20, Kazakhstan has 862,862 cases and 10,763 deaths.
- Kazakhstan has 860,424 cases and 10,726 deaths as of September 19.
- Kazakhstan has 857,643 cases and 10,670 deaths as of September 18.
All citizens, including expatriates, will receive COVID-19 vaccines for free. Kuwait is importing one million vaccines from Pfizer, 1.7 million from Moderna, and three million doses of the Oxford-AstraZeneca vaccines and will commence a nationwide program from January.
- As of September 19, Kuwait has 411,180 cases and 2,439 deaths.
- Kuwait has 411,124 cases and 2,438 deaths as of September 18.
- As of September 16, Kuwait has 411,018 cases and 2,436 deaths.
Kyrgyzstan is sourcing vaccines from Russia with the Sputnik V vaccine expected to be rolled out in Q2 2021.
- As of September 20, Kyrgyzstan has 177,780 cases and 2,590 deaths.
- Kyrgyzstan has 177,722 cases and 2,588 deaths as of September 19.
- Kyrgyzstan has 177,653 cases and 2,586 deaths as of September 18.
Lebanon is sourcing vaccines from Pfizer and is expected to take deliveries from mid-February 2021.
- Lebanon has 618,278 cases and 8,236 deaths as of September 19.
- As of September 18, Lebanon has 617,662 cases and 8,232 deaths.
- Lebanon has 617,036 cases and 8,228 deaths as of September 17.
Macao is part of the Covax scheme and is expected to receive 1.4 million doses of vaccine. The product will cost Pataca 300 (US$40). Roll out is expected in late Q1 2021.
- As of August 4, Macau has 63 cases.
- Macau has 59 cases as of July 25.
- As of July 24, Macau has 58 cases.
The Maldives will receive vaccines under the Covax program and will receive enough products to reach 20 percent of its population. Roll out is expected in Q2 2021.
- The Maldives has 83,576 cases and 229 deaths as of September 19.
- The Maldives has 83,494 cases and 229 deaths as of September 18.
- As of September 17, the Maldives has 83,332 cases and 229 deaths.
Mongolia is in discussions with Astra-Zeneca to purchase COVID-19 vaccines and is also part of the Covax scheme. Roll out is expected in Q2 2021.
- As of September 20, Mongolia has 277,997 cases and 1,119 deaths.
- Mongolia has 275,146 cases and 1,108 deaths as of September 19.
- Mongolia has 272,369 cases and 1,096 deaths as of September 18.
Nepal will source COVID-19 vaccines under the Covax program and will also purchase supplies from India. The rollout is expected from Q2 2021.
- As of September 20, Nepal has 785,541 cases and 11,048 deaths.
- Nepal has 784,566 cases and 11,040 deaths as of September 19.
- Nepal has 783,910 cases and 11,028 deaths as of September 18.
North Korea is expected to receive Covid-19 vaccines from China, with rumors that North Korean Leader Kim Jong-Un has already received treatment as part of medical trials.
- North Korea has reported its first case on July 25, the city of Kaesong is under lockdown.
Oman has sourced COVID-19 vaccines from Gavi and is buying additional supplies from Astra-Zeneca and Pfizer. Roll out will commence from January 2021 with each shot costing 10 Rial (US$24).
- Oman has 303,459 cases and 4,093 deaths as of September 20.
- As of September 19, Oman has 303,423 cases and 4,093 deaths.
- Oman has 303,309 cases and 4,092 deaths as of September 16.
Pakistan is also suffering from a Polio epidemic and is struggling with dealing with both. However, it has stated it will provide the vaccine for free with national inoculations to start from April 2021.
- As of September 20, Pakistan has 1,226,008 cases and 27,246 deaths.
- Pakistan has 1,223,841 cases and 27,206 deaths as of September 19.
- Pakistan has 1,221,261 cases and 27,135 deaths as of September 18.
Israel is currently negotiating with the UAE to provide 1.5 million doses of vaccine to Palestine. The product is expected to be the Russian Sputnik V treatment and should be available to Palestinians in Q2 2021.
- As of September 19, Palestine has 384,390 cases and 3,919 deaths.
- Palestine has 382,584 cases and 3,909 deaths as of September 18.
- Palestine has 381,854 cases and 3,890 deaths as of September 17.
Qatar has signed an agreement with Moderna to provide Covid-19 vaccines and has also signed deals with Pfizer and BioNTech. These will be made available from late Q1 2021.
- As of September 20, Qatar has 235,626 cases and 604 deaths.
- Qatar has 235,487 cases and 604 deaths as of September 19.
- Qatar has 235,386 cases and 604 deaths as of September 18.
A complete overview of the availability and production of Russian Covid-19 vaccines and costs can be found here.
- As of September 20, Russia has 7,294,672 cases and 198,996 deaths.
- Russia has 7,274,928 cases and 198,218 deaths as of September 19.
- Our new Russia-specific updates here.
Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO) said last week that it had signed an agreement with the German biopharmaceutical company CureVac to provide Covid-19 vaccine. It plans to cover 70 percent of its population by the end of 2021 with treatment being available for free. The initial roll out is expected to be at the end of Q1 2021.
- Saudi Arabia has 546,612 cases and 8,667 deaths as of September 20.
- As of September 19, Saudi Arabia has 546,549 cases and 8,661 deaths.
- Saudi Arabia has 546,479 cases and 8,656 deaths as of September 18.
South Korea has reached a deal with AstraZeneca to purchase its coronavirus vaccine candidate and is in final talks with global drug-makers including AstraZeneca, Pfizer Inc, and Johnson & Johnson over their vaccines. It launched a preliminary review of AstraZeneca’s product in October for potential fast-track approval. Roll out is expected in Q1 2021.
- South Korea has 287,536 cases and 2,409 deaths as of September 20.
- South Korea has 285,931 cases and 2,404 deaths as of September 19.
- As of September 18, South Korea has 284,022 cases and 2,394 deaths.
Sri Lanka is to receive 4.2 million doses of the COVID-19 vaccine from Gavi, enough to cover 20 percent of the population. It has not yet released information on when these will be made available.
- Sri Lanka has 504,491 cases and 12,125 deaths as of September 19.
- As of September 18, Sri Lanka has 502,758 cases and 12,022 deaths.
- Sri Lanka has 500,772 cases and 11,938 deaths as of September 17.
Taiwan has been developing its own vaccine and is also part of the Covax scheme. It has stated it will be able to manufacture enough of its own product for 50 percent population coverage with roll-out expected in Q1 2021.
- As of September 20, Taiwan has 16,147 cases and 840 deaths.
- Taiwan has 16,141 cases and 840 deaths as of September 19.
- Taiwan has 16,129 cases and 839 deaths as of September 18.
Turkey has purchased 50 million doses of China’s Cornavac, manufactured by Sinopharm. These will be made available for free to the most at-risk population, inoculations start on December 11. Other treatments will be purchased and made available via medical outlets during the year and sold at cost price, and are likely to include products from Pfizer and Russia.
- As of September 19, Turkey has 6,847,259 cases and 61,574 deaths.
- Turkey has 6,820,861 cases and 61,361 deaths as of September 18.
- Turkey has 6,794,700 cases and 61,140 deaths as of September 17.
United Arab Emirates
The UAE is expected to authorize the use of China’s Sinopharm vaccine which is nearing the end of its clinical trials in the Emirates. The UAE’s Prime Minister, Sheikh Mohammed bin Rashid Al Maktoum was inoculated as part of the testing. Roll out is expected in Q1 2021. The UAE is also manufacturing the vaccine and hopes to produce between 75-100 million doses during the year.
- As of September 19, the UAE has 732,690 cases and 2,075 deaths.
- The UAE has 732,299 cases and 2,073 deaths as of September 18.
- The UAE has 731,828 cases and 2,071 deaths as of September 17.
Uzbekistan has been trailing China’s Anhui Zhifei Longcom Biopharmaceutical vaccine in addition to vaccines made by China’s Sinopharm and Russia’s Sputnik V. Roll out is expected in Q1 2021.
- As of September 19, Uzbekistan has 168,437 cases and 1,188 deaths.
- Uzbekistan has 167,858 cases and 1,184 deaths as of September 18.
- Uzbekistan has 167,268 cases and 1,179 deaths as of September 17.
Yemen is suffering from war and diseases such as diphtheria, while local politicians have made wild claims that the country will develop its own COVID-19 vaccine. It is a member of the Gavi program and relief is likely to come from humanitarian sources.
- As of September 19, Yemen has 8,667 cases and 1,643 deaths.
- Yemen has 8,630 cases and 1,638 deaths as of September 18.
- Yemen has 8,593 cases and 1,628 deaths as of September 17.
- China’s Support Policies for Businesses Under COVID-19: A Comprehensive List
- The China Sourcing Alternatives in ASEAN – Complimentary Country Guides
ASEAN Briefing is produced by Dezan Shira & Associates. The firm assists foreign investors throughout Asia and maintains offices throughout ASEAN, including in Singapore, Hanoi, Ho Chi Minh City, and Da Nang in Vietnam, Munich, and Esen in Germany, Boston, and Salt Lake City in the United States, Milan, Conegliano, and Udine in Italy, in addition to Jakarta, and Batam in Indonesia. We also have partner firms in Malaysia, Bangladesh, the Philippines, and Thailand as well as our practices in China and India. Please contact us at firstname.lastname@example.org or visit our website at www.dezshira.com.